Otsuka Pharmaceutical has accelerated FDA approval for Voyxact to reduce proteinuria in adults with primary IgAN at disease progression risk.
Otsuka Pharmaceutical Development & Commercialization, Inc. and Otsuka Pharmaceutical, Co. Ltd. (Otsuka) today announce the U ...
Does turkey make you tired? Experts share the best time to eat Thanksgiving dinner - Chefs on whether turkey actually makes ...
As Thanksgiving approaches, we gather in a celebration of gratitude. Throughout November, reminders to “being thankful” are ...
While General Dynamics has surged past the Nasdaq Composite in 2025, it has slightly lagged behind the index recently.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback